A Randomized, Open-label Study of MabThera Maintenance Therapy Compared With no Further Therapy After a Brief Induction With Chemotherapy Plus MabThera on Failure-free Survival in Treatment-naïve Elderly Patients With Advanced Follicular Lymphoma
A Randomized, Open-label Study of MabThera Maintenance Therapy Compared With no Further Therapy After a Brief Induction With Chemotherapy Plus MabThera on Failure-free Survival in Treatment-naïve Elderly Patients With Advanced Follicular Lymphoma
This study will evaluate the efficacy and safety of brief induction therapy with a chemotherapeutic regimen containing MabThera, followed by either maintenance therapy with MabThera or no further therapy. The anticipated time on study treatment is 1-2 years, and the target sample size is 100-500 individuals.
Inclusion Criteria:
Exclusion Criteria:
Bari, Apulia 70124, Italy
San Giovanni Rotondo, Apulia 71013, Italy
Naples, Campania 80131, Italy
Nocera Inferiore, Campania 84014, Italy
Piacenza, Emilia-Romagna 29100, Italy
Udine, Friuli Venezia Giulia 33100, Italy
Rome, Lazio 00161, Italy
Milan, Lombardy 20133, Italy
Milan, Lombardy 20162, Italy
Candiolo, Piedmont 10060, Italy
Orbassano, Piedmont 10043, Italy
Turin, Piedmont 10126, Italy
Turin, Piedmont 10126, Italy
Via S. Sofia 78, Sicily 95123, Italy
Bolzano, Trentino-Alto Adige 39100, Italy
Perugia, Umbria 06126, Italy